[{"NetIncomeLoss_1_Q3_USD":-10138000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":19426833.0,"InterestAndOtherIncome_3_Q3_USD":655000.0,"InterestAndOtherIncome_1_Q3_USD":72000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"AccruedLiabilitiesCurrent_0_Q3_USD":7798000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":-2977000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-716000.0,"Depreciation_3_Q3_USD":900000.0,"Depreciation_1_Q3_USD":300000.0,"GrantsReceivable_0_Q3_USD":2800000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q3_USD":46323000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_3_Q3_USD":-1442000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q3_USD":743000.0,"AssetsCurrent_0_Q3_USD":164158000.0,"LongTermDebt_0_Q3_USD":14427000.0,"ContractWithCustomerLiability_0_Q3_USD":33275000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":3779785.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":87000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":444000.0,"ForeignCurrencyTransactionGainLossRealized_3_Q3_USD":700000.0,"ForeignCurrencyTransactionGainLossRealized_1_Q3_USD":-700000.0,"IncomeTaxesPaidNet_3_Q3_USD":124000.0,"CommonStockSharesIssued_0_Q3_shares":20935853.0,"Assets_0_Q3_USD":170059000.0,"ShareBasedCompensation_3_Q3_USD":4950000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":1459000.0,"CommonStockParOrStatedValuePerShare_0_Q3_GBP":0.01,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":18504013.0,"DeferredFinanceCostsNet_0_Q3_USD":573000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":7154000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_0_Q3_USD":7340000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":7363000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":23091000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":1329000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_Q3_USD":-1486000.0,"AccountsReceivableNetCurrent_0_Q3_USD":2828000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":-465000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":-668000.0,"IncreaseDecreaseInDeferredRevenue_3_Q3_USD":27782000.0,"CommonStockValue_0_Q3_USD":264000.0,"DepreciationDepletionAndAmortization_3_Q3_USD":944000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":61099000.0,"PaymentsOfStockIssuanceCosts_1_Q3_USD":1800000.0,"ProceedsFromIssuanceOfDebt_3_Q3_USD":15000000.0,"DeferredRevenueNoncurrent_0_Q3_USD":26082000.0,"FairValueAdjustmentOfWarrants_1_Q3_USD":0.0,"FairValueAdjustmentOfWarrants_3_Q3_USD":0.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q3_USD":-10138000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_3_Q3_USD":-33577000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-9395000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-35019000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":193000.0,"OtherAssetsNoncurrent_0_Q3_USD":2403000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":0.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":645000.0,"Cash_0_Q3_USD":149842000.0,"Liabilities_0_Q3_USD":60508000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_3_Q3_USD":369000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":18351000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":773000.0,"CommonStockSharesAuthorized_0_Q3_shares":31995653.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":6542000.0,"ContractWithCustomerLiabilityRevenueRecognized_3_Q3_USD":3496000.0,"ContractWithCustomerLiabilityRevenueRecognized_1_Q3_USD":1267000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":3496000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":-34245000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":-10603000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":1510000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-1172000.0,"ProceedsFromWarrantExercises_3_Q3_USD":1000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":766000.0,"LiabilitiesCurrent_0_Q3_USD":17047000.0,"DeferredRevenueCurrent_0_Q3_USD":7193000.0,"AccountsPayableCurrent_0_Q3_USD":2056000.0,"PaymentsOfDebtIssuanceCosts_3_Q3_USD":373000.0,"NonoperatingIncomeExpense_3_Q3_USD":655000.0,"NonoperatingIncomeExpense_1_Q3_USD":72000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":149842000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":5518000.0,"LongTermDebtNoncurrent_0_Q3_USD":14427000.0,"ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress_3_Q3_USD":-319000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q3_pure":0.0861,"IncreaseDecreaseInOtherOperatingAssets_3_Q3_USD":719000.0,"AdditionalPaidInCapital_0_Q3_USD":246391000.0,"NoncurrentAssets_0_Q3_USD":3498000.0,"NumberOfOperatingSegments_3_Q3_segment":2.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_0_Q3_USD":1148000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":2039000.0,"NetIncomeLoss_3_Q3_USD":-33577000.0,"CommonStockSharesOutstanding_0_Q3_shares":20935853.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":2685000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":57725000.0,"LeaseCost_1_Q3_USD":379000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":3842000.0,"OperatingIncomeLoss_3_Q3_USD":-34900000.0,"OperatingIncomeLoss_1_Q3_USD":-10675000.0,"ProceedsFromIssuanceInitialPublicOffering_3_Q3_USD":46373000.0,"OperatingLeaseCost_3_Q3_USD":669000.0,"OperatingLeaseCost_1_Q3_USD":226000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":170059000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":2559000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_0_Q3_USD":7262000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":4950000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":1510000.0,"PropertyPlantAndEquipmentGross_0_Q3_USD":5535000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":684000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":226000.0,"OperatingExpenses_3_Q3_USD":41442000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_3_Q3_USD":1030000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-1.81,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.52,"ProfitLoss_3_Q3_USD":-33577000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":2307000.0,"OtherLiabilitiesCurrent_0_Q3_USD":90000.0,"StockholdersEquity_0_Q3_USD":109551000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":716000.0,"DebtInstrumentCarryingAmount_0_Q3_USD":15000000.0,"VariableLeaseCost_3_Q3_USD":456000.0,"VariableLeaseCost_1_Q3_USD":153000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-134127000.0,"LeaseCost_3_Q3_USD":1125000.0,"OperatingExpenses_1_Q3_USD":14517000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":1723000.0,"Ticker":"BCYC","CIK":"1761612","name":"BICYCLE THERAPEUTICS PLC","OfficialName":"Bicycle Therapeutics plc American Depositary Shares","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"738781455.0","Country":"United Kingdom","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20201105"}]